Wen-feng Xu

Title: The Innovations of Wen-feng Xu

Introduction

Wen-feng Xu is a notable inventor based in Mukilteo, WA (US). He has made significant contributions to the field of protease-activated receptors, holding a total of 3 patents. His work focuses on the development of polynucleotide and polypeptide molecules that play crucial roles in biological responses and cellular signaling.

Latest Patents

One of his latest patents is related to the protease-activated receptor PAR4 (ZCHEMR2). This invention involves polynucleotide and polypeptide molecules for PAR4, which is a novel member of the protease-activated receptor family. The polypeptides and polynucleotides he developed mediate biological responses and cellular signaling in response to proteases. The protease cleavage of PAR4 exposes an extracellular amino terminal portion that serves as a ligand for the PAR4 receptor. This receptor may be utilized as a target in drug screening, aiding in the identification of both proteinaceous and non-proteinaceous PAR4 agonists and antagonists. Additionally, the invention includes antibodies to the PAR4 polypeptides.

Career Highlights

Wen-feng Xu has worked with Zymogenetics, Inc., where he contributed to various innovative projects. His expertise in the field has allowed him to make significant advancements in understanding protease-activated receptors.

Collaborations

Throughout his career, Wen-feng Xu has collaborated with notable individuals such as Scott R Presnell and David P Yee. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Wen-feng Xu's contributions to the field of protease-activated receptors demonstrate his innovative spirit and dedication to advancing scientific knowledge. His patents and collaborations reflect his commitment to improving drug screening and therapeutic targets.